IRIS
MERLOTTI, DANIELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.913
EU - Europa 4.438
AS - Asia 2.728
SA - Sud America 561
AF - Africa 52
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 7
Totale 13.707
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.842
RU - Federazione Russa 1.079
CN - Cina 1.034
SG - Singapore 926
GB - Regno Unito 770
IE - Irlanda 732
BR - Brasile 473
UA - Ucraina 386
IT - Italia 361
SE - Svezia 333
DE - Germania 253
HK - Hong Kong 228
FR - Francia 222
KR - Corea 170
VN - Vietnam 144
FI - Finlandia 138
IN - India 52
AR - Argentina 41
CA - Canada 40
ES - Italia 33
TR - Turchia 31
BD - Bangladesh 27
NL - Olanda 22
BE - Belgio 20
PL - Polonia 20
ZA - Sudafrica 19
IQ - Iraq 18
MX - Messico 18
CI - Costa d'Avorio 14
LT - Lituania 14
AT - Austria 12
JP - Giappone 12
EC - Ecuador 11
PK - Pakistan 11
CL - Cile 9
CZ - Repubblica Ceca 9
ID - Indonesia 9
SA - Arabia Saudita 9
IR - Iran 8
VE - Venezuela 8
CO - Colombia 6
EU - Europa 6
HU - Ungheria 6
UZ - Uzbekistan 6
GR - Grecia 5
NP - Nepal 5
PE - Perù 5
UY - Uruguay 5
AU - Australia 4
DK - Danimarca 4
EG - Egitto 4
IL - Israele 4
SY - Repubblica araba siriana 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
KE - Kenya 3
KZ - Kazakistan 3
MA - Marocco 3
OM - Oman 3
PA - Panama 3
PT - Portogallo 3
TH - Thailandia 3
AM - Armenia 2
BH - Bahrain 2
CH - Svizzera 2
CR - Costa Rica 2
ET - Etiopia 2
GE - Georgia 2
JO - Giordania 2
KG - Kirghizistan 2
LB - Libano 2
LU - Lussemburgo 2
LV - Lettonia 2
MW - Malawi 2
MY - Malesia 2
NZ - Nuova Zelanda 2
RS - Serbia 2
TN - Tunisia 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
DZ - Algeria 1
EE - Estonia 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
NI - Nicaragua 1
NO - Norvegia 1
PF - Polinesia Francese 1
PW - Palau 1
PY - Paraguay 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
Totale 13.705
Salva come PNG Salva come JPEG
Città #
Dallas 782
Dublin 723
Fairfield 692
Southend 639
Singapore 461
Ashburn 415
Santa Clara 369
Chandler 319
Jacksonville 308
Woodbridge 304
Moscow 283
Houston 260
Beijing 249
Wilmington 248
Cambridge 240
Seattle 237
Hong Kong 226
Ann Arbor 179
Hefei 178
Seoul 170
Princeton 138
Nanjing 92
Siena 87
Los Angeles 71
The Dalles 63
Helsinki 58
Buffalo 46
Ho Chi Minh City 46
Boardman 45
Munich 43
San Diego 43
Nanchang 42
Shanghai 42
New York 40
London 39
São Paulo 37
Council Bluffs 36
Dong Ket 36
Milan 32
San Mateo 30
Dearborn 27
Shenyang 26
Tianjin 26
Redondo Beach 25
Columbus 24
Izmir 24
Hanoi 23
Bengaluru 22
San Francisco 21
Brussels 20
Málaga 19
Redwood City 19
Rome 19
Düsseldorf 17
Hebei 17
Kunming 17
Chicago 16
Jiaxing 16
Warsaw 16
Changsha 15
Abidjan 14
Boston 14
Brooklyn 14
Denver 14
Rio de Janeiro 14
Turku 14
Venezia 14
Belo Horizonte 13
Toronto 13
Montreal 12
Poplar 12
Florence 11
Johannesburg 11
Norwalk 11
Nuremberg 11
Portsmouth 11
Stockholm 11
Tokyo 11
Bologna 10
Brasília 10
Fremont 10
Hangzhou 10
Porto Alegre 10
Atlanta 9
Da Nang 9
Guangzhou 9
Zhengzhou 9
Jinan 8
Lancaster 8
Phoenix 8
Vienna 8
Amsterdam 7
Brno 7
Campinas 7
Curitiba 7
Dhaka 7
Falkenstein 7
Frankfurt am Main 7
Lanzhou 7
Lappeenranta 7
Totale 9.163
Salva come PNG Salva come JPEG
Nome #
Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes 276
Comparison of intravenous and intramuscular neridronate regimens for the treatment of Paget disease of bone 247
Aromatase activity and bone loss in men 239
A non-synonymous TNFRSF11A variation increases NFkB activity and the severity of Paget's disease 230
Bazedoxifene for the prevention of postmenopausal osteoporosis 228
Comparison of different intravenous bisphosphonate regimens for Paget's disease of bone. 223
The association of body composition and sexhormones with quantitative ultrasound parameters at the calcaneus and phalanxes in elderly women. 214
Common susceptibility alleles and SQSTM1 mutations predict disease extent and severity in a multinational study of patients with Paget's disease 210
Variation in Bone Turnover Markers in Professional Sport Players During Training is Mediated by Changes in Sclerostin Levels 202
Endocrine actions of osteocalcin 202
ZNF687 Mutations in Severe Paget Disease of Bone Associated with Giant Cell Tumor 201
The usefulness of quantitative ultrasound (QUS) measurements in the evaluation of skeletal status in newborns and in children 199
Corretto uso dei marcatori del rimodellamento osseo 199
Aromatase activity and bone loss 196
SQSTM1 gene analysis and gene-environment interaction in Paget's disease of bone 193
Bone metabolism in men: role of aromatase activity 191
Longitudinal association between sex hormone levels, bone loss and bone turnover in elderly men. 188
Lasofoxifene, from the preclinical drug discovery to the treatment of postmenopausal osteoporosis 180
Mild brachydactyly type A1 maps to chromosome 2q35-q36 and is caused by a novel IHH mutation in a three generation family 179
The influence of weight and length at birth on bone status during childhood as evaluated by QUS 179
The effects of zoledronic acid on serum lipids in multiple myeloma patients 174
Vitamin D receptor gene polymorphisms predict acquired resistance to clodronate treatment in patients with Paget's disease of bone 174
Appropriate models for novel osteoporosis drug discovery and future perspectives 170
CALCITRIOLO E OSTEOPOROSI 169
Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene 168
Paget disease of bone-associated UBA domain mutations of SQSTM1 exert distinct effects on protein structure and function 166
Mutation of PFN1 gene in an early onset, polyostotic Paget-like disease 166
Epidemiological, clinical, and genetic characteristics of Paget's disease of bone in a rural area of Calabria, Southern Italy 165
aromatase deficiency and male osteoporosis 165
The use of intravenous aminobisphosphonates for the treatment of Paget's disease of bone 165
Pharmacokinetic evaluation of toremifene and its clinical implications for the treatment of osteoporosis 163
Update on the pharmacogenetics of the vitamin D receptor and osteoporosis 162
Preventive Role of Vitamin D Supplementation for Acute Phase Reaction after Bisphosphonate Infusion in Paget's Disease 162
Quantitative ultrasound and dual-energy X-ray absorptiometry in the prediction of fragility fracture in men 161
Feasibility of quantitative ultrasound measurements on the humerus of newborn infants for the assessment of the skeletal status. 159
Prevalence of Paget’s disease of bone in Italy 159
Giant cell tumor occurring in familial Paget's disease of bone: report of clinical characteristics and linkage analysis of a large pedigree 156
Paget's disease of bone: epidemiology, pathogenesis and pharmacotherapy 156
The effects of recombinant TSH on bone turnover markers and serum osteoprotegerin and RANKL levels 154
Perspectives in the treatment and prevention of osteoporosis 152
Analysis of Usual Consumption of Vitamin D Among Adult Individuals in Italy 151
Mechanisms of impaired bone strength in type 1 and 2 diabetes 151
Ospemifene use in postmenopausal women 149
Lasofoxifene: a third-generation selective estrogen receptor modulator for the prevention and treatment of osteoporosis 148
Apporto nutrizionale di vitamina D in Italia [Feeding and vitamin D in Italy] 147
Bone fragility in men: where are we? 145
MicroRNAs in bone diseases 143
FSHR gene polymorphisms influence bone mineral density and bone turnover in postmenopausal women 142
Identification of Single Nucleotide Polymorphisms (SNPs) contributing to bone mineral density and fractures: a DNA microarray based study 140
Update on the pathogenesis and genetics of Paget's disease of bone 139
Lasofoxifene: a new-generation SERM for the treatment of postmenopausal osteoporosis 139
Vitamin D Status in Paget Disease of Bone and Efficacy-Safety Profile of Cholecalciferol Treatment in Pagetic Patients with Hypovitaminosis D. 139
Lasofoxifene: Evidence of its therapeutic value in osteoporosis 135
Vescicole extracellulari e metabolismo osseo: ruolo e possibili implicazioni cliniche 133
Steroid hormone receptor gene polymorphisms and osteoporosis: a pharmacogenomic review 133
Infection by CagA-Positive Helicobacter pylori Strains and Bone Fragility: A Prospective Cohort Study 133
Recent advances in models for screening potential osteoporosis drugs 132
null 128
Raloxifene in breast cancer prevention 128
Interleukin-6 trans-signaling and pathological low back pain in patients with Paget disease of bone 127
Cortisol secretion, sensitivity, and activity are associated with hypertension in postmenopausal eucortisolemic women 122
null 122
Relationship of sex hormones with bone turnover markers, bone ultrasounds and BMD at multiple sites in men and women 121
Role of Advanced Glycation End-Products and Oxidative Stress in Type-2-Diabetes-Induced Bone Fragility and Implications on Fracture Risk Stratification 118
Vitamin D deficiency and primary hyperparathyroidism 118
The Potential Role of miRNAs as New Biomarkers for Osteoporosis 118
Emerging therapeutic targets for osteoporosis 116
Vitamin D and COVID-19 severity and related mortality: a prospective study in Italy 115
Effects of Bisphosphonate Treatment on Circulating Lipid and Glucose Levels in Patients with Metabolic Bone Disorders 114
MANAGEMENT STRATEGIES FOR OSTEOPOROSIS IN THE AGING MALE: FOCUS ON ZOLEDRONIC ACID 113
Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes 111
Drug treatment strategies for paget’s disease: relieving pain and preventing progression 110
Dietary Vitamin D Intake in Italian Subjects: Validation of a Frequency Food Questionnaire (FFQ) 109
Selective estrogen receptor modulators for postmenopausal osteoporosis: current state of development 109
Diagnosis and treatment of Paget’s disease of bone: position paper from the Italian Society of Osteoporosis, Mineral Metabolism and Skeletal Diseases (SIOMMMS) 106
Micro-RNA expression profiling in Paget's disease of bone 106
null 105
la genetica dell'osteoporosi 104
null 103
Treatment options for glucocorticoid-induced osteoporosis 102
Efficacy and safety of abaloparatide for the treatment of post-menopausal osteoporosis 102
Hypovitaminosis D and organ damage in patients with arterial hypertension: a multicenter double blind randomised controlled trial of cholecalciferol supplementation (HYPODD) : study design, clinical procedures and treatment protocol 101
Paget’s disease of bone: an update on epidemiology, pathogenesis and pharmacotherapy 100
Treatment needs and current options for postmenopausal osteoporosis 100
Paget's disease of bone 100
Current options for the treatment of Paget's disease of the bone 99
Oncogenic osteomalacia 99
Vitamin D Deficiency in COVID-19 Patients and Role of Calcifediol Supplementation 97
Professional sport activity and micronutrients: effects on bone mass 97
Clinical Characteristics and Evolution of Giant Cell Tumor Occurring in Paget's Disease of Bone 94
Management of bone fragility in type 2 diabetes:Perspective from an interdisciplinary expert panel 88
Prediction of hypertension, diabetes and fractures in eucortisolemic women by measuring parameters of cortisol milieu 78
Energy metabolism and ketogenic diets: What about the skeletal health? a narrative review and a prospective vision for planning clinical trials on this issue 70
Validation of the clinical consensus recommendations on the management of fracture risk in postmenopausal women with type 2 diabetes 70
Updates in epidemiology, pathophysiology and management strategies of glucocorticoid-induced osteoporosis 66
Pathophysiology and Management of Type 2 Diabetes Mellitus Bone Fragility 58
Totale 13.885
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.621
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.621
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021803 0 0 0 0 0 152 33 230 112 93 96 87
2021/2022855 52 107 41 109 24 25 36 23 44 105 88 201
2022/20231.233 81 90 184 164 120 262 26 95 117 33 40 21
2023/20241.157 123 48 112 45 19 245 389 17 7 28 33 91
2024/20252.610 47 128 188 128 382 189 96 149 234 121 243 705
2025/20263.614 503 863 566 643 978 61 0 0 0 0 0 0
Totale 13.885